Literature DB >> 21960218

Kinase inhibitor selectivity profiling using differential scanning fluorimetry.

Oleg Fedorov1, Frank H Niesen, Stefan Knapp.   

Abstract

Fast, robust, and inexpensive screening methods are the heart of drug discovery processes. Moreover, it is useful to have access to several established assay formats, for validation purposes. If a targeted protein is an enzyme, the logical and widely used approach is the direct measurement of the effect of the added ligands on its activity. A variety of enzymatic assay formats have been successfully applied for inhibitor screening of protein kinases. However, enzymatic assays require an active enzyme with a known substrate and often time-consuming assay optimization. Several alternative approaches have been recently developed that detect binding of ligands to proteins. This chapter overviews and provides the experimental protocol of the successful application of differential scanning fluorimetry (DSF) in our laboratory for fast and robust screening of medium-sized (<10,000) inhibitor libraries. DSF monitors the thermal stabilization of the native protein structure upon ligand binding. It allows selectivity profiling of any protein kinase without prior knowledge of either substrate or activity of the kinase under investigation. Comparative studies revealed that generated data is highly reproducible and correlates well with the results from other ligand binding methodologies, direct binding constants as well as enzymatic assays.

Mesh:

Substances:

Year:  2012        PMID: 21960218     DOI: 10.1007/978-1-61779-337-0_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  52 in total

1.  Comprehensive characterization of the Published Kinase Inhibitor Set.

Authors:  Jonathan M Elkins; Vita Fedele; Marta Szklarz; Kamal R Abdul Azeez; Eidarus Salah; Jowita Mikolajczyk; Sergei Romanov; Nikolai Sepetov; Xi-Ping Huang; Bryan L Roth; Ayman Al Haj Zen; Denis Fourches; Eugene Muratov; Alex Tropsha; Joel Morris; Beverly A Teicher; Mark Kunkel; Eric Polley; Karen E Lackey; Francis L Atkinson; John P Overington; Paul Bamborough; Susanne Müller; Daniel J Price; Timothy M Willson; David H Drewry; Stefan Knapp; William J Zuercher
Journal:  Nat Biotechnol       Date:  2015-10-26       Impact factor: 54.908

2.  Analysis of protein stability and ligand interactions by thermal shift assay.

Authors:  Kathy Huynh; Carrie L Partch
Journal:  Curr Protoc Protein Sci       Date:  2015-02-02

3.  SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK).

Authors:  Christopher R M Asquith; Benedict-Tilman Berger; Jing Wan; James M Bennett; Stephen J Capuzzi; Daniel J Crona; David H Drewry; Michael P East; Jonathan M Elkins; Oleg Fedorov; Paulo H Godoi; Debra M Hunter; Stefan Knapp; Susanne Müller; Chad D Torrice; Carrow I Wells; H Shelton Earp; Timothy M Willson; William J Zuercher
Journal:  J Med Chem       Date:  2019-02-26       Impact factor: 7.446

4.  Cytokinesis defect in BY-2 cells caused by ATP-competitive kinase inhibitors.

Authors:  Elena Kozgunova; Tetsuya Higashiyama; Daisuke Kurihara
Journal:  Plant Signal Behav       Date:  2016-10-02

5.  Integrated Target-Based and Phenotypic Screening Approaches for the Identification of Anti-Tubercular Agents That Bind to the Mycobacterial Adenylating Enzyme MbtA.

Authors:  Lindsay Ferguson; Geoff Wells; Sanjib Bhakta; James Johnson; Junitta Guzman; Tanya Parish; Robin A Prentice; Federico Brucoli
Journal:  ChemMedChem       Date:  2019-09-23       Impact factor: 3.466

6.  Mutant Variants of the Substrate-Binding Protein DppA from Escherichia coli Enhance Growth on Nonstandard γ-Glutamyl Amide-Containing Peptides.

Authors:  Tilmann Kuenzl; Xiaochun Li-Blatter; Puneet Srivastava; Piet Herdewijn; Timothy Sharpe; Sven Panke
Journal:  Appl Environ Microbiol       Date:  2018-06-18       Impact factor: 4.792

7.  High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships.

Authors:  Frank H Niesen; Lena Schultz; Ajit Jadhav; Chitra Bhatia; Kunde Guo; David J Maloney; Ewa S Pilka; Minghua Wang; Udo Oppermann; Tom D Heightman; Anton Simeonov
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

8.  First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes.

Authors:  Zeynep Yurtsever; Dhara A Patel; Daniel L Kober; Alvin Su; Chantel A Miller; Arthur G Romero; Michael J Holtzman; Tom J Brett
Journal:  Biochim Biophys Acta       Date:  2016-06-29

9.  Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib.

Authors:  Sebastian Mathea; Kamal R Abdul Azeez; Eidarus Salah; Cynthia Tallant; Finn Wolfreys; Rebecca Konietzny; Roman Fischer; Hua Jane Lou; Paul E Brennan; Gisela Schnapp; Alexander Pautsch; Benedikt M Kessler; Benjamin E Turk; Stefan Knapp
Journal:  ACS Chem Biol       Date:  2016-03-31       Impact factor: 5.100

10.  Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase.

Authors:  Christopher R M Asquith; Tuomo Laitinen; James M Bennett; Paulo H Godoi; Michael P East; Graham J Tizzard; Lee M Graves; Gary L Johnson; Ronna E Dornsife; Carrow I Wells; Jonathan M Elkins; Timothy M Willson; William J Zuercher
Journal:  ChemMedChem       Date:  2017-11-27       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.